Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine | National Health and Nutrition Examination Survey (NHANES Survey) 2013 | ||
NPO3578 | Andrographis paniculata | Species | Acanthaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT299 | Individual Protein | Androgen Receptor | Rattus norvegicus | IC50 | = | 309029.54 | nM | 16134935 |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 12589.3 | nM | PubChem BioAssay data set |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 50118.7 | nM | PubChem BioAssay data set |
NPT347 | Cell Line | Lymphoblastoid cells | Homo sapiens | Potency | = | 79432.8 | nM | PubChem BioAssay data set |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 1412.5 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 31622.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 23109.3 | nM | PubChem BioAssay data set | ||
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 29081 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 25918.5 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | 5011.9 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Potency | 3548.1 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 0.7 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 1412.5 | nM | PubChem BioAssay data set | |
NPT99 | Individual Protein | Peroxisome proliferator-activated receptor gamma | Homo sapiens | Potency | 5623.4 | nM | PubChem BioAssay data set | |
NPT99 | Individual Protein | Peroxisome proliferator-activated receptor gamma | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT901 | Individual Protein | UDP-glucuronosyltransferase 1-1 | Homo sapiens | Activity | = | 50 | pm/min/mg | 10836148 |
NPT702 | Individual Protein | UDP-glucuronosyltransferase 1-6 | Homo sapiens | Activity | = | 50 | pm/min/mg | 10836148 |
NPT703 | Individual Protein | UDP-glucuronosyltransferase 1-9 | Homo sapiens | Activity | = | 1200 | pm/min/mg | 10836148 |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 66166 | nM | PubChem BioAssay data set | |
NPT155 | Individual Protein | Aryl hydrocarbon receptor | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 53080.4 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 30637.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 47307.9 | nM | PubChem BioAssay data set | |
NPT331 | Organism | Ralstonia solanacearum | Ralstonia solanacearum | IZ | = | 17 | mm | 10.1584/jpestics.G10-84 |
NPT2 | Others | Unspecified | Potency | 48557.7 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 9770 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 30637.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 870.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 138 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6113.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21131.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24541.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26806.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3466.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3063.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 50118.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24336.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 26603.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2168.4 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 17228.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8634.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21689.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54941 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2433.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 14960.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27306 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10963.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68589.6 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 6165.2 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 24336.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 61644.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61130.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 489.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12299.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7761.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61652.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 76958.8 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6917.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 6859 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 2753.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2454.1 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 54941 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 7943.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19331.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1548.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 17228.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13685.4 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC94298 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC27633 |
0.9818 | High Similarity | NPC131192 |
0.9402 | High Similarity | NPC184219 |
0.9397 | High Similarity | NPC69403 |
0.9397 | High Similarity | NPC291189 |
0.9386 | High Similarity | NPC61779 |
0.9322 | High Similarity | NPC49938 |
0.9244 | High Similarity | NPC110211 |
0.9244 | High Similarity | NPC204579 |
0.9237 | High Similarity | NPC221798 |
0.9231 | High Similarity | NPC67300 |
0.9091 | High Similarity | NPC2596 |
0.9083 | High Similarity | NPC475236 |
0.9035 | High Similarity | NPC220540 |
0.9016 | High Similarity | NPC194979 |
0.9016 | High Similarity | NPC226855 |
0.9 | High Similarity | NPC29883 |
0.8934 | High Similarity | NPC473744 |
0.8926 | High Similarity | NPC95309 |
0.8909 | High Similarity | NPC184658 |
0.8852 | High Similarity | NPC158654 |
0.8803 | High Similarity | NPC94637 |
0.88 | High Similarity | NPC302844 |
0.8783 | High Similarity | NPC81808 |
0.873 | High Similarity | NPC114116 |
0.8729 | High Similarity | NPC328459 |
0.8729 | High Similarity | NPC90522 |
0.872 | High Similarity | NPC473777 |
0.8696 | High Similarity | NPC11824 |
0.8661 | High Similarity | NPC226699 |
0.8655 | High Similarity | NPC72977 |
0.8644 | High Similarity | NPC273282 |
0.8644 | High Similarity | NPC474890 |
0.8644 | High Similarity | NPC161943 |
0.864 | High Similarity | NPC307732 |
0.864 | High Similarity | NPC42292 |
0.8636 | High Similarity | NPC304638 |
0.8632 | High Similarity | NPC128825 |
0.8629 | High Similarity | NPC2401 |
0.8609 | High Similarity | NPC17693 |
0.8583 | High Similarity | NPC156124 |
0.8583 | High Similarity | NPC1321 |
0.8583 | High Similarity | NPC304929 |
0.8571 | High Similarity | NPC6984 |
0.8571 | High Similarity | NPC104854 |
0.856 | High Similarity | NPC94810 |
0.8548 | High Similarity | NPC121104 |
0.8522 | High Similarity | NPC114682 |
0.8522 | High Similarity | NPC212718 |
0.8509 | High Similarity | NPC95172 |
0.85 | High Similarity | NPC233282 |
0.8492 | Intermediate Similarity | NPC285776 |
0.8492 | Intermediate Similarity | NPC109778 |
0.8482 | Intermediate Similarity | NPC219913 |
0.848 | Intermediate Similarity | NPC293453 |
0.8475 | Intermediate Similarity | NPC83718 |
0.8475 | Intermediate Similarity | NPC128249 |
0.8462 | Intermediate Similarity | NPC170718 |
0.8455 | Intermediate Similarity | NPC253746 |
0.845 | Intermediate Similarity | NPC18646 |
0.8438 | Intermediate Similarity | NPC283823 |
0.8438 | Intermediate Similarity | NPC153783 |
0.8438 | Intermediate Similarity | NPC159418 |
0.8438 | Intermediate Similarity | NPC66158 |
0.8425 | Intermediate Similarity | NPC470831 |
0.8425 | Intermediate Similarity | NPC214702 |
0.8425 | Intermediate Similarity | NPC264145 |
0.8421 | Intermediate Similarity | NPC31274 |
0.8421 | Intermediate Similarity | NPC206341 |
0.8413 | Intermediate Similarity | NPC8005 |
0.8413 | Intermediate Similarity | NPC78662 |
0.8403 | Intermediate Similarity | NPC240664 |
0.839 | Intermediate Similarity | NPC322358 |
0.8387 | Intermediate Similarity | NPC165556 |
0.8385 | Intermediate Similarity | NPC156892 |
0.8385 | Intermediate Similarity | NPC291454 |
0.8364 | Intermediate Similarity | NPC171843 |
0.8362 | Intermediate Similarity | NPC23332 |
0.8362 | Intermediate Similarity | NPC57879 |
0.8359 | Intermediate Similarity | NPC111888 |
0.8359 | Intermediate Similarity | NPC477407 |
0.8348 | Intermediate Similarity | NPC234639 |
0.8346 | Intermediate Similarity | NPC327457 |
0.8346 | Intermediate Similarity | NPC86774 |
0.8333 | Intermediate Similarity | NPC79332 |
0.8333 | Intermediate Similarity | NPC186098 |
0.8333 | Intermediate Similarity | NPC52358 |
0.8333 | Intermediate Similarity | NPC80694 |
0.8319 | Intermediate Similarity | NPC470860 |
0.8305 | Intermediate Similarity | NPC252004 |
0.8295 | Intermediate Similarity | NPC239855 |
0.8293 | Intermediate Similarity | NPC475192 |
0.8288 | Intermediate Similarity | NPC52472 |
0.8281 | Intermediate Similarity | NPC198249 |
0.8281 | Intermediate Similarity | NPC219892 |
0.8281 | Intermediate Similarity | NPC189823 |
0.8276 | Intermediate Similarity | NPC183648 |
0.8271 | Intermediate Similarity | NPC469911 |
0.8261 | Intermediate Similarity | NPC17525 |
0.8258 | Intermediate Similarity | NPC478200 |
0.8258 | Intermediate Similarity | NPC33144 |
0.8258 | Intermediate Similarity | NPC221104 |
0.825 | Intermediate Similarity | NPC122117 |
0.8246 | Intermediate Similarity | NPC317592 |
0.8244 | Intermediate Similarity | NPC235115 |
0.8244 | Intermediate Similarity | NPC475111 |
0.824 | Intermediate Similarity | NPC4164 |
0.8226 | Intermediate Similarity | NPC174991 |
0.822 | Intermediate Similarity | NPC242136 |
0.8217 | Intermediate Similarity | NPC323379 |
0.8217 | Intermediate Similarity | NPC327204 |
0.8209 | Intermediate Similarity | NPC470842 |
0.8209 | Intermediate Similarity | NPC472035 |
0.8209 | Intermediate Similarity | NPC478201 |
0.8203 | Intermediate Similarity | NPC12694 |
0.8203 | Intermediate Similarity | NPC247779 |
0.8198 | Intermediate Similarity | NPC245561 |
0.8182 | Intermediate Similarity | NPC135837 |
0.8182 | Intermediate Similarity | NPC70380 |
0.8182 | Intermediate Similarity | NPC249912 |
0.8182 | Intermediate Similarity | NPC276775 |
0.8182 | Intermediate Similarity | NPC92754 |
0.8182 | Intermediate Similarity | NPC301915 |
0.8182 | Intermediate Similarity | NPC241089 |
0.8182 | Intermediate Similarity | NPC261292 |
0.8175 | Intermediate Similarity | NPC154275 |
0.8174 | Intermediate Similarity | NPC260952 |
0.8168 | Intermediate Similarity | NPC27407 |
0.8168 | Intermediate Similarity | NPC142027 |
0.816 | Intermediate Similarity | NPC6888 |
0.816 | Intermediate Similarity | NPC145134 |
0.8158 | Intermediate Similarity | NPC238115 |
0.8158 | Intermediate Similarity | NPC127676 |
0.8154 | Intermediate Similarity | NPC477281 |
0.8154 | Intermediate Similarity | NPC477280 |
0.8154 | Intermediate Similarity | NPC19719 |
0.8145 | Intermediate Similarity | NPC46634 |
0.8136 | Intermediate Similarity | NPC231717 |
0.8134 | Intermediate Similarity | NPC158472 |
0.8134 | Intermediate Similarity | NPC326065 |
0.8125 | Intermediate Similarity | NPC60558 |
0.8125 | Intermediate Similarity | NPC214246 |
0.812 | Intermediate Similarity | NPC94248 |
0.812 | Intermediate Similarity | NPC476003 |
0.812 | Intermediate Similarity | NPC116842 |
0.812 | Intermediate Similarity | NPC191835 |
0.812 | Intermediate Similarity | NPC239943 |
0.812 | Intermediate Similarity | NPC212693 |
0.812 | Intermediate Similarity | NPC183700 |
0.8115 | Intermediate Similarity | NPC161617 |
0.8115 | Intermediate Similarity | NPC473767 |
0.8115 | Intermediate Similarity | NPC156654 |
0.811 | Intermediate Similarity | NPC305518 |
0.811 | Intermediate Similarity | NPC37512 |
0.811 | Intermediate Similarity | NPC128428 |
0.811 | Intermediate Similarity | NPC281020 |
0.8108 | Intermediate Similarity | NPC225060 |
0.8108 | Intermediate Similarity | NPC35448 |
0.8108 | Intermediate Similarity | NPC78701 |
0.8106 | Intermediate Similarity | NPC156307 |
0.8106 | Intermediate Similarity | NPC471345 |
0.8099 | Intermediate Similarity | NPC45104 |
0.8099 | Intermediate Similarity | NPC217423 |
0.8092 | Intermediate Similarity | NPC175943 |
0.8092 | Intermediate Similarity | NPC155098 |
0.8088 | Intermediate Similarity | NPC469615 |
0.8087 | Intermediate Similarity | NPC1065 |
0.8087 | Intermediate Similarity | NPC187913 |
0.8077 | Intermediate Similarity | NPC128348 |
0.8077 | Intermediate Similarity | NPC112192 |
0.8077 | Intermediate Similarity | NPC164236 |
0.8077 | Intermediate Similarity | NPC313618 |
0.8077 | Intermediate Similarity | NPC309717 |
0.8077 | Intermediate Similarity | NPC308037 |
0.8077 | Intermediate Similarity | NPC189106 |
0.8077 | Intermediate Similarity | NPC66384 |
0.8077 | Intermediate Similarity | NPC64359 |
0.8074 | Intermediate Similarity | NPC184053 |
0.8074 | Intermediate Similarity | NPC158634 |
0.8074 | Intermediate Similarity | NPC478217 |
0.8074 | Intermediate Similarity | NPC313123 |
0.807 | Intermediate Similarity | NPC2518 |
0.8067 | Intermediate Similarity | NPC109241 |
0.8062 | Intermediate Similarity | NPC185497 |
0.806 | Intermediate Similarity | NPC105456 |
0.806 | Intermediate Similarity | NPC139634 |
0.806 | Intermediate Similarity | NPC105525 |
0.806 | Intermediate Similarity | NPC12218 |
0.806 | Intermediate Similarity | NPC75763 |
0.806 | Intermediate Similarity | NPC268052 |
0.806 | Intermediate Similarity | NPC19622 |
0.806 | Intermediate Similarity | NPC32360 |
0.806 | Intermediate Similarity | NPC92655 |
0.806 | Intermediate Similarity | NPC112789 |
0.806 | Intermediate Similarity | NPC225036 |
0.8053 | Intermediate Similarity | NPC94343 |
0.8051 | Intermediate Similarity | NPC139946 |
0.8051 | Intermediate Similarity | NPC268388 |
0.8045 | Intermediate Similarity | NPC125417 |
0.8045 | Intermediate Similarity | NPC110899 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC94298 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9545 | Approved |
0.9 | High Similarity | NPD9265 | Clinical (unspecified phase) |
0.8632 | High Similarity | NPD9493 | Approved |
0.8583 | High Similarity | NPD230 | Phase 1 |
0.8203 | Intermediate Similarity | NPD3764 | Approved |
0.8134 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8077 | Intermediate Similarity | NPD1240 | Approved |
0.8074 | Intermediate Similarity | NPD4628 | Phase 3 |
0.8 | Intermediate Similarity | NPD9717 | Approved |
0.7969 | Intermediate Similarity | NPD9494 | Approved |
0.7955 | Intermediate Similarity | NPD1607 | Approved |
0.7949 | Intermediate Similarity | NPD74 | Approved |
0.7949 | Intermediate Similarity | NPD9266 | Approved |
0.7926 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7917 | Intermediate Similarity | NPD1241 | Discontinued |
0.7876 | Intermediate Similarity | NPD1238 | Approved |
0.7863 | Intermediate Similarity | NPD9263 | Approved |
0.7863 | Intermediate Similarity | NPD9267 | Approved |
0.7863 | Intermediate Similarity | NPD9264 | Approved |
0.7857 | Intermediate Similarity | NPD1608 | Approved |
0.7836 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7812 | Intermediate Similarity | NPD1203 | Approved |
0.7794 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7786 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7778 | Intermediate Similarity | NPD3134 | Approved |
0.7721 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7721 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7717 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7712 | Intermediate Similarity | NPD1358 | Approved |
0.768 | Intermediate Similarity | NPD9268 | Approved |
0.766 | Intermediate Similarity | NPD9509 | Clinical (unspecified phase) |
0.7643 | Intermediate Similarity | NPD6799 | Approved |
0.7638 | Intermediate Similarity | NPD422 | Phase 1 |
0.7636 | Intermediate Similarity | NPD9258 | Approved |
0.7636 | Intermediate Similarity | NPD9256 | Approved |
0.7619 | Intermediate Similarity | NPD1778 | Approved |
0.7619 | Intermediate Similarity | NPD17 | Approved |
0.76 | Intermediate Similarity | NPD1894 | Discontinued |
0.7578 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7578 | Intermediate Similarity | NPD3972 | Approved |
0.7554 | Intermediate Similarity | NPD3750 | Approved |
0.7554 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.754 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7521 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.7521 | Intermediate Similarity | NPD9261 | Approved |
0.7518 | Intermediate Similarity | NPD2935 | Discontinued |
0.7517 | Intermediate Similarity | NPD7411 | Suspended |
0.75 | Intermediate Similarity | NPD6190 | Approved |
0.75 | Intermediate Similarity | NPD1535 | Discovery |
0.75 | Intermediate Similarity | NPD2182 | Approved |
0.7481 | Intermediate Similarity | NPD1019 | Discontinued |
0.7458 | Intermediate Similarity | NPD164 | Approved |
0.7419 | Intermediate Similarity | NPD9281 | Approved |
0.7405 | Intermediate Similarity | NPD1164 | Approved |
0.7394 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD2796 | Approved |
0.7388 | Intermediate Similarity | NPD411 | Approved |
0.7383 | Intermediate Similarity | NPD7075 | Discontinued |
0.7368 | Intermediate Similarity | NPD6832 | Phase 2 |
0.736 | Intermediate Similarity | NPD256 | Approved |
0.736 | Intermediate Similarity | NPD255 | Approved |
0.7353 | Intermediate Similarity | NPD447 | Suspended |
0.7343 | Intermediate Similarity | NPD2534 | Approved |
0.7343 | Intermediate Similarity | NPD2532 | Approved |
0.7343 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7343 | Intermediate Similarity | NPD2533 | Approved |
0.7338 | Intermediate Similarity | NPD2344 | Approved |
0.7333 | Intermediate Similarity | NPD520 | Approved |
0.7329 | Intermediate Similarity | NPD6599 | Discontinued |
0.7328 | Intermediate Similarity | NPD3225 | Approved |
0.7328 | Intermediate Similarity | NPD1283 | Approved |
0.7319 | Intermediate Similarity | NPD2799 | Discontinued |
0.7297 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7297 | Intermediate Similarity | NPD7819 | Suspended |
0.7293 | Intermediate Similarity | NPD454 | Approved |
0.7292 | Intermediate Similarity | NPD2186 | Approved |
0.728 | Intermediate Similarity | NPD690 | Clinical (unspecified phase) |
0.7279 | Intermediate Similarity | NPD3142 | Approved |
0.7279 | Intermediate Similarity | NPD3140 | Approved |
0.7273 | Intermediate Similarity | NPD9259 | Approved |
0.7273 | Intermediate Similarity | NPD2797 | Approved |
0.7273 | Intermediate Similarity | NPD9257 | Approved |
0.7254 | Intermediate Similarity | NPD2354 | Approved |
0.7234 | Intermediate Similarity | NPD1243 | Approved |
0.7231 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.723 | Intermediate Similarity | NPD6801 | Discontinued |
0.7222 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7211 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7203 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7203 | Intermediate Similarity | NPD7440 | Discontinued |
0.72 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7197 | Intermediate Similarity | NPD1876 | Approved |
0.7194 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7194 | Intermediate Similarity | NPD7033 | Discontinued |
0.7194 | Intermediate Similarity | NPD3748 | Approved |
0.7183 | Intermediate Similarity | NPD7003 | Approved |
0.7182 | Intermediate Similarity | NPD111 | Approved |
0.7179 | Intermediate Similarity | NPD9495 | Approved |
0.7177 | Intermediate Similarity | NPD1609 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD1237 | Approved |
0.7165 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7165 | Intermediate Similarity | NPD9568 | Approved |
0.7154 | Intermediate Similarity | NPD3847 | Discontinued |
0.7153 | Intermediate Similarity | NPD1511 | Approved |
0.7153 | Intermediate Similarity | NPD943 | Approved |
0.7143 | Intermediate Similarity | NPD3455 | Phase 2 |
0.7143 | Intermediate Similarity | NPD7458 | Discontinued |
0.7133 | Intermediate Similarity | NPD2309 | Approved |
0.7133 | Intermediate Similarity | NPD3887 | Approved |
0.7132 | Intermediate Similarity | NPD2313 | Discontinued |
0.7132 | Intermediate Similarity | NPD6798 | Discontinued |
0.7132 | Intermediate Similarity | NPD3268 | Approved |
0.713 | Intermediate Similarity | NPD1202 | Approved |
0.7123 | Intermediate Similarity | NPD920 | Approved |
0.7114 | Intermediate Similarity | NPD1934 | Approved |
0.7107 | Intermediate Similarity | NPD9697 | Approved |
0.7103 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7099 | Intermediate Similarity | NPD1281 | Approved |
0.7099 | Intermediate Similarity | NPD1201 | Approved |
0.7097 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7092 | Intermediate Similarity | NPD2353 | Approved |
0.7092 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7092 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD6007 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD2798 | Approved |
0.7086 | Intermediate Similarity | NPD3882 | Suspended |
0.708 | Intermediate Similarity | NPD6233 | Phase 2 |
0.708 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7077 | Intermediate Similarity | NPD4626 | Approved |
0.7073 | Intermediate Similarity | NPD6831 | Clinical (unspecified phase) |
0.7069 | Intermediate Similarity | NPD2934 | Approved |
0.7069 | Intermediate Similarity | NPD2933 | Approved |
0.7068 | Intermediate Similarity | NPD196 | Phase 1 |
0.7067 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD8166 | Discontinued |
0.7055 | Intermediate Similarity | NPD1512 | Approved |
0.7055 | Intermediate Similarity | NPD6273 | Approved |
0.7054 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7049 | Intermediate Similarity | NPD968 | Approved |
0.7047 | Intermediate Similarity | NPD6386 | Approved |
0.7047 | Intermediate Similarity | NPD6385 | Approved |
0.7039 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7039 | Intermediate Similarity | NPD3749 | Approved |
0.7027 | Intermediate Similarity | NPD3226 | Approved |
0.7023 | Intermediate Similarity | NPD3496 | Discontinued |
0.702 | Intermediate Similarity | NPD3817 | Phase 2 |
0.702 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD1470 | Approved |
0.7009 | Intermediate Similarity | NPD2859 | Approved |
0.7009 | Intermediate Similarity | NPD2860 | Approved |
0.7007 | Intermediate Similarity | NPD1670 | Discontinued |
0.7007 | Intermediate Similarity | NPD5403 | Approved |
0.7007 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7007 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD940 | Approved |
0.7 | Intermediate Similarity | NPD5691 | Approved |
0.7 | Intermediate Similarity | NPD846 | Approved |
0.6992 | Remote Similarity | NPD4379 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD3451 | Clinical (unspecified phase) |
0.6986 | Remote Similarity | NPD5401 | Approved |
0.6978 | Remote Similarity | NPD6355 | Discontinued |
0.6978 | Remote Similarity | NPD1933 | Approved |
0.6972 | Remote Similarity | NPD7266 | Discontinued |
0.6957 | Remote Similarity | NPD6663 | Approved |
0.6954 | Remote Similarity | NPD2801 | Approved |
0.695 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.695 | Remote Similarity | NPD651 | Clinical (unspecified phase) |
0.6944 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD2684 | Approved |
0.6934 | Remote Similarity | NPD5952 | Clinical (unspecified phase) |
0.6933 | Remote Similarity | NPD958 | Approved |
0.6929 | Remote Similarity | NPD6651 | Approved |
0.6923 | Remote Similarity | NPD1432 | Clinical (unspecified phase) |
0.6912 | Remote Similarity | NPD5736 | Approved |
0.6906 | Remote Similarity | NPD825 | Approved |
0.6906 | Remote Similarity | NPD826 | Approved |
0.6906 | Remote Similarity | NPD4307 | Phase 2 |
0.6905 | Remote Similarity | NPD228 | Approved |
0.6901 | Remote Similarity | NPD5404 | Approved |
0.6901 | Remote Similarity | NPD5405 | Approved |
0.6901 | Remote Similarity | NPD5406 | Approved |
0.6901 | Remote Similarity | NPD5408 | Approved |
0.6901 | Remote Similarity | NPD4476 | Approved |
0.6901 | Remote Similarity | NPD4477 | Approved |
0.6889 | Remote Similarity | NPD3266 | Approved |
0.6889 | Remote Similarity | NPD3267 | Approved |
0.6885 | Remote Similarity | NPD5909 | Discontinued |
0.6875 | Remote Similarity | NPD2800 | Approved |
0.6875 | Remote Similarity | NPD5953 | Discontinued |
0.6871 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.687 | Remote Similarity | NPD5585 | Approved |
0.6867 | Remote Similarity | NPD3684 | Discontinued |
0.6861 | Remote Similarity | NPD2614 | Approved |
0.6859 | Remote Similarity | NPD6232 | Discontinued |
0.6857 | Remote Similarity | NPD555 | Phase 2 |
0.6857 | Remote Similarity | NPD4340 | Discontinued |
0.6855 | Remote Similarity | NPD290 | Approved |
PubChem CID   | 7175 |
ChEMBL   | CHEMBL194014 |
ZINC   |
Molecular Weight:   | 180.08 |
ALogP:   | -0.7765 |
MLogP:   | 2.23 |
XLogP:   | 2.172 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 46.53 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 13 |